Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.350
+0.090 (3.99%)
Nov 21, 2024, 1:43 PM EST - Market open

Oramed Pharmaceuticals Statistics

Total Valuation

ORMP has a market cap or net worth of $94.74 million. The enterprise value is -$52.33 million.

Market Cap 94.74M
Enterprise Value -52.33M

Important Dates

The next estimated earnings date is Tuesday, December 3, 2024, after market close.

Earnings Date Dec 3, 2024
Ex-Dividend Date n/a

Share Statistics

ORMP has 40.31 million shares outstanding. The number of shares has increased by 2.51% in one year.

Current Share Class 40.31M
Shares Outstanding 40.31M
Shares Change (YoY) +2.51%
Shares Change (QoQ) -1.67%
Owned by Insiders (%) 11.08%
Owned by Institutions (%) 12.52%
Float 33.66M

Valuation Ratios

The trailing PE ratio is 21.42.

PE Ratio 21.42
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.58
P/TBV Ratio 0.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 27.08, with a Debt / Equity ratio of 0.00.

Current Ratio 27.08
Quick Ratio 26.99
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.33

Financial Efficiency

Return on equity (ROE) is 2.89% and return on invested capital (ROIC) is -4.29%.

Return on Equity (ROE) 2.89%
Return on Assets (ROA) -4.12%
Return on Capital (ROIC) -4.29%
Revenue Per Employee n/a
Profits Per Employee $343,462
Employee Count 13
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ORMP has paid $2.77 million in taxes.

Income Tax 2.77M
Effective Tax Rate 38.65%

Stock Price Statistics

The stock price has increased by +10.24% in the last 52 weeks. The beta is 1.77, so ORMP's price volatility has been higher than the market average.

Beta (5Y) 1.77
52-Week Price Change +10.24%
50-Day Moving Average 2.37
200-Day Moving Average 2.51
Relative Strength Index (RSI) 44.77
Average Volume (20 Days) 108,342

Short Selling Information

The latest short interest is 299,983, so 0.74% of the outstanding shares have been sold short.

Short Interest 299,983
Short Previous Month 298,473
Short % of Shares Out 0.74%
Short % of Float 0.89%
Short Ratio (days to cover) 3.80

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -13.06M
Pretax Income 10.46M
Net Income 4.47M
EBITDA -12.85M
EBIT -13.06M
Earnings Per Share (EPS) $0.11
Full Income Statement

Balance Sheet

The company has $142.30 million in cash and $429,000 in debt, giving a net cash position of $142.52 million or $3.54 per share.

Cash & Cash Equivalents 142.30M
Total Debt 429,000
Net Cash 142.52M
Net Cash Per Share $3.54
Equity (Book Value) 155.52M
Book Value Per Share 3.89
Working Capital 137.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.92 million and capital expenditures -$10,000, giving a free cash flow of -$7.93 million.

Operating Cash Flow -7.92M
Capital Expenditures -10,000
Free Cash Flow -7.93M
FCF Per Share -$0.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -931.60%

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.51%
Shareholder Yield -2.51%
Earnings Yield 4.90%
FCF Yield -8.70%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 0.083333:1.

Last Split Date Jan 23, 2013
Split Type Reverse
Split Ratio 0.083333:1

Scores

ORMP has an Altman Z-Score of 5.51 and a Piotroski F-Score of 2.

Altman Z-Score 5.51
Piotroski F-Score 2